Bioject Medical Technologies In (BJCT) 0.1940 $BJCT
Global Insulin Delivery Devices Market 2014-2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers
M2 - Tue Jun 24, 3:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6qt2hc/insulin_delivery) has announced the addition of the "Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers" report to their offering. 'Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers' looks at the market, competitive landscape, and trends for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment's pipeline products and gives details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Scope - Key geographies: the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil. - Information on market size for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories. - Annualized market revenue data forecast to 2019 and company share data for 2012. - Qualitative analysis of key trends in the insulin delivery devices market. - Information on the competitive landscape and the leading technologies of key players: Novo Nordisk A/S, Medtronic, Inc., Sanofi, Eli Lilly and Company, Becton, Dickinson and Company, Animas Corporation, Insulet Corporation, F. Hoffmann-La Roche Ltd., Abbott Laboratories. - Information on reimbursement trends and market access for key countries. Reasons to buy - Develop business strategies by understanding the trends and developments driving the global insulin delivery devices market. - Design and enhance your product development, marketing, and sales strategies. - Exploit M&A opportunities by identifying the market players with the most innovative pipelines. - Develop market-entry and market-expansion strategies. - Identify the key players best positioned to take advantage of the emerging market opportunities. - Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return. - Identify, understand and capitalize on the next big thing in the insulin delivery devices market landscape. - Make more informed business decisions from insightful and in-depth analysis of the global insulin delivery devices market and the factors shaping it. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Diabetes - Disease Overview 4 Diabetes - Epidemiology 5 Global Insulin Delivery Devices Market: Device Overview 6 Global Insulin Delivery Devices Market: Market Characterization 7 Global Insulin Delivery Devices Market: Segment Analysis and Forecasts 8 Global Insulin Delivery Devices Market: Country Analysis and Forecasts 9 Global Insulin Delivery Devices Market: Reimbursement System 10 Global Insulin Delivery Devices Market: Competitive Landscape 11 Global Insulin Delivery Devices Market: Product Pipeline Analysis 12 Global Insulin Delivery Devices Market: Consolidation Landscape 13 Appendix Companies Mentioned - Abbott Laboratories - Animas - Antares Pharma - Asante Solutions - Becton, Dickinson and Company - Bioject Medical Technologies - Eli Lilly - F. Hoffmann-La Roche - Injex - Equidyne Systems - Insulet - Medtronic - Novo Nordisk (Subsidiary of Novo A/S) - Owen Mumford - Sanofi - Shanghai Fosun Pharmaceutical - Tandem Diabetes Care - Tonghua Dongbao Pharmaceutical - Ypsomed For more information visit http://www.researchandmarkets.com/research/6q...n_delivery
Bioject announces the appointment of a distributor for China
PR Newswire - Mon May 12, 9:15AM CDT
Bioject Medical Technologies Inc. (OTC Pink: BJCT), a leading developer of needle-free injection systems continues to expand global access to the company's technology. Bioject has signed an agreement with Caligor RX, Inc. to use its China distribution partners to sell its commercial devices in the region.
Bioject Seeking to Restructure Its Balance Sheet
PR Newswire - Thu Mar 20, 3:30PM CDT
Bioject Medical Technologies Inc. (OTC Pink: BJCT), a developer and manufacturer of needle-free injection therapy systems, today announced it is seeking to restructure its balance sheet, in order to secure necessary operating capital. After attempts to obtain necessary operating capital from third parties over a period of twelve months were unsuccessful, Bioject received an advance on March 17, 2014, of $500,000 from two of its directors, pending completion of a restructuring plan, approved by its Board of Directors, but subject to final negotiated agreements and shareholder and debt holder consents.
Bioject's Distributor Meditrend International Receives Australian Device Registration
PR Newswire - Wed Jan 22, 8:00AM CST
Bioject Medical Technologies Inc. (OTC Pink: BJCT), a leading developer and manufacturer of needle-free injection technology, today announced that Meditrend International, Bioject's Australian/New Zealand Distributor has received the Australian Register of Therapeutic Goods Certificate for the Biojector Needle-free injection Management System (Biojector® 2000), the Vial Transfer Spike and theBioject® ZetaJet(TM) Needle-free Injection Therapy System. The Biojector® 2000 is indicated for delivery of subcutaneous, intramuscular or intradermal injections of vaccines and other pharmaceutical injectables. The Bioject® Zetajet(TM) is indicated for delivery of subcutaneous or intramuscular injections of vaccines and other injectable drugs into standard injection sites. Both may be used by healthcare providers and by patients with authorization from their physicians for prescribed medications.
Disposable Syringe Markets Report: Comprehensive 2013 Analysis
M2 - Fri Jun 21, 4:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rs2pqx/disposable) has announced the addition of the "Disposable Syringe Markets 2013" report to their offering. The report examines the disposable syringe market. It provides detailed forecasts for the traditional and safety engineered sharps markets. It describes the major drivers and restraints, technology trends, and industry challenges for the disposable syringe market. It examines the markets for blood collection sets, hypodermic access syringes and needles, sharps-based insulin delivery devices, and other specialty syringes and needles. Additionally, the study considers the disposable syringe supplies utilized in clinics and by patients in their homes to diagnose and monitor diseases, as well as to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing g
Poland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018
M2 - Fri Apr 12, 11:06AM CDT
Research and Markets has announced the addition of the "Poland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. Poland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018, a new report by Global Markets Direct, provides key market data on the Ireland Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 4 market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global
Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018
M2 - Wed Mar 27, 4:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v5s9t8/ireland_drug) has announced the addition of the "Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018, a new report by Global Markets Direct, provides key market data on the Ireland Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 4 market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments. Scope - Market size and company share data for Drug Delivery Devices market cate
Bioject Enters into Three Distribution Agreements
Business Wire - Thu Mar 21, 8:00AM CDT
Bioject Medical Technologies Inc. (OTC Pink: BJCT), a developer and manufacturer of needle-free injection therapy systems, today announced that it has entered into three international distribution agreements, two in the Pacific Rim region and one in the Middle East. The agreements call for the sale of the Biojector(R)2000 gas-powered device, the Bioject(R) ZetaJet(TM) spring-powered device and accessories through qualified medical device groups located in Australia, the Republic of the Philippines, and North Africa. The agreements provide for distribution in multiple territories throughout the regions.
Canada Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Tue Mar 12, 11:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qq78sw/canada_drug) has announced the addition of GlobalData's new report "Canada Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. This new report, Canada Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the Canada Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials
Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Fri Mar 08, 6:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/8flr2d/asiapacific_drug) has announced the addition of GlobalData's new report "Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. This new report provides key market data on the Asia Pacific Drug Delivery Devices market - Japan, China, India, and Australia. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Scope - 2011 compa
United Kingdom Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Thu Mar 07, 8:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/ggj4tv/united_kingdom) has announced the addition of GlobalData's new report "United Kingdom Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. Our new report, United Kingdom Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the United Kingdom Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with informat
China Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Thu Mar 07, 8:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/9sdrf2/china_drug) has announced the addition of GlobalData's new report "China Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. Our new report, China Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the China Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and p
North America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Thu Mar 07, 6:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/bhd7b3/north_america) has announced the addition of GlobalData's new report "North America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. This new report, North America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the North America Drug Delivery Devices market - United States and Canada. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. This report is built using data and information sourced
Bioject Reports Unaudited Year-End and Quarterly 2012 Financial Results
Business Wire - Mon Feb 11, 7:00PM CST
Bioject Medical Technologies Inc. (OTC Pink:BJCT), a developer and manufacturer of needle-free injection therapy systems, today reported unaudited financial results for the year and quarter ended December 31, 2012. The financial results are unaudited and actual results may vary.
Global Insulin Delivery Devices Market 2014-2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers
M2 - Tue Jun 24, 3:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6qt2hc/insulin_delivery) has announced the addition of the "Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers" report to their offering. 'Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers' looks at the market, competitive landscape, and trends for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment's pipeline products and gives details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Scope - Key geographies: the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil. - Information on market size for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories. - Annualized market revenue data forecast to 2019 and company share data for 2012. - Qualitative analysis of key trends in the insulin delivery devices market. - Information on the competitive landscape and the leading technologies of key players: Novo Nordisk A/S, Medtronic, Inc., Sanofi, Eli Lilly and Company, Becton, Dickinson and Company, Animas Corporation, Insulet Corporation, F. Hoffmann-La Roche Ltd., Abbott Laboratories. - Information on reimbursement trends and market access for key countries. Reasons to buy - Develop business strategies by understanding the trends and developments driving the global insulin delivery devices market. - Design and enhance your product development, marketing, and sales strategies. - Exploit M&A opportunities by identifying the market players with the most innovative pipelines. - Develop market-entry and market-expansion strategies. - Identify the key players best positioned to take advantage of the emerging market opportunities. - Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return. - Identify, understand and capitalize on the next big thing in the insulin delivery devices market landscape. - Make more informed business decisions from insightful and in-depth analysis of the global insulin delivery devices market and the factors shaping it. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Diabetes - Disease Overview 4 Diabetes - Epidemiology 5 Global Insulin Delivery Devices Market: Device Overview 6 Global Insulin Delivery Devices Market: Market Characterization 7 Global Insulin Delivery Devices Market: Segment Analysis and Forecasts 8 Global Insulin Delivery Devices Market: Country Analysis and Forecasts 9 Global Insulin Delivery Devices Market: Reimbursement System 10 Global Insulin Delivery Devices Market: Competitive Landscape 11 Global Insulin Delivery Devices Market: Product Pipeline Analysis 12 Global Insulin Delivery Devices Market: Consolidation Landscape 13 Appendix Companies Mentioned - Abbott Laboratories - Animas - Antares Pharma - Asante Solutions - Becton, Dickinson and Company - Bioject Medical Technologies - Eli Lilly - F. Hoffmann-La Roche - Injex - Equidyne Systems - Insulet - Medtronic - Novo Nordisk (Subsidiary of Novo A/S) - Owen Mumford - Sanofi - Shanghai Fosun Pharmaceutical - Tandem Diabetes Care - Tonghua Dongbao Pharmaceutical - Ypsomed For more information visit http://www.researchandmarkets.com/research/6q...n_delivery
Bioject announces the appointment of a distributor for China
PR Newswire - Mon May 12, 9:15AM CDT
Bioject Medical Technologies Inc. (OTC Pink: BJCT), a leading developer of needle-free injection systems continues to expand global access to the company's technology. Bioject has signed an agreement with Caligor RX, Inc. to use its China distribution partners to sell its commercial devices in the region.
Bioject Seeking to Restructure Its Balance Sheet
PR Newswire - Thu Mar 20, 3:30PM CDT
Bioject Medical Technologies Inc. (OTC Pink: BJCT), a developer and manufacturer of needle-free injection therapy systems, today announced it is seeking to restructure its balance sheet, in order to secure necessary operating capital. After attempts to obtain necessary operating capital from third parties over a period of twelve months were unsuccessful, Bioject received an advance on March 17, 2014, of $500,000 from two of its directors, pending completion of a restructuring plan, approved by its Board of Directors, but subject to final negotiated agreements and shareholder and debt holder consents.
Bioject's Distributor Meditrend International Receives Australian Device Registration
PR Newswire - Wed Jan 22, 8:00AM CST
Bioject Medical Technologies Inc. (OTC Pink: BJCT), a leading developer and manufacturer of needle-free injection technology, today announced that Meditrend International, Bioject's Australian/New Zealand Distributor has received the Australian Register of Therapeutic Goods Certificate for the Biojector Needle-free injection Management System (Biojector® 2000), the Vial Transfer Spike and theBioject® ZetaJet(TM) Needle-free Injection Therapy System. The Biojector® 2000 is indicated for delivery of subcutaneous, intramuscular or intradermal injections of vaccines and other pharmaceutical injectables. The Bioject® Zetajet(TM) is indicated for delivery of subcutaneous or intramuscular injections of vaccines and other injectable drugs into standard injection sites. Both may be used by healthcare providers and by patients with authorization from their physicians for prescribed medications.
Disposable Syringe Markets Report: Comprehensive 2013 Analysis
M2 - Fri Jun 21, 4:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rs2pqx/disposable) has announced the addition of the "Disposable Syringe Markets 2013" report to their offering. The report examines the disposable syringe market. It provides detailed forecasts for the traditional and safety engineered sharps markets. It describes the major drivers and restraints, technology trends, and industry challenges for the disposable syringe market. It examines the markets for blood collection sets, hypodermic access syringes and needles, sharps-based insulin delivery devices, and other specialty syringes and needles. Additionally, the study considers the disposable syringe supplies utilized in clinics and by patients in their homes to diagnose and monitor diseases, as well as to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing g
Poland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018
M2 - Fri Apr 12, 11:06AM CDT
Research and Markets has announced the addition of the "Poland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. Poland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018, a new report by Global Markets Direct, provides key market data on the Ireland Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 4 market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global
Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018
M2 - Wed Mar 27, 4:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v5s9t8/ireland_drug) has announced the addition of the "Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018" report to their offering. Ireland Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2018, a new report by Global Markets Direct, provides key market data on the Ireland Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 4 market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments. Scope - Market size and company share data for Drug Delivery Devices market cate
Bioject Enters into Three Distribution Agreements
Business Wire - Thu Mar 21, 8:00AM CDT
Bioject Medical Technologies Inc. (OTC Pink: BJCT), a developer and manufacturer of needle-free injection therapy systems, today announced that it has entered into three international distribution agreements, two in the Pacific Rim region and one in the Middle East. The agreements call for the sale of the Biojector(R)2000 gas-powered device, the Bioject(R) ZetaJet(TM) spring-powered device and accessories through qualified medical device groups located in Australia, the Republic of the Philippines, and North Africa. The agreements provide for distribution in multiple territories throughout the regions.
Canada Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Tue Mar 12, 11:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qq78sw/canada_drug) has announced the addition of GlobalData's new report "Canada Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. This new report, Canada Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the Canada Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials
Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Fri Mar 08, 6:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/8flr2d/asiapacific_drug) has announced the addition of GlobalData's new report "Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. This new report provides key market data on the Asia Pacific Drug Delivery Devices market - Japan, China, India, and Australia. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Scope - 2011 compa
United Kingdom Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Thu Mar 07, 8:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/ggj4tv/united_kingdom) has announced the addition of GlobalData's new report "United Kingdom Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. Our new report, United Kingdom Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the United Kingdom Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with informat
China Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Thu Mar 07, 8:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/9sdrf2/china_drug) has announced the addition of GlobalData's new report "China Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. Our new report, China Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the China Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Infusion Systems, Metered Dose Inhaler Devices, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and p
North America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others
M2 - Thu Mar 07, 6:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/bhd7b3/north_america) has announced the addition of GlobalData's new report "North America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others" to their offering. This new report, North America Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others provides key market data on the North America Drug Delivery Devices market - United States and Canada. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants. This report is built using data and information sourced
Bioject Reports Unaudited Year-End and Quarterly 2012 Financial Results
Business Wire - Mon Feb 11, 7:00PM CST
Bioject Medical Technologies Inc. (OTC Pink:BJCT), a developer and manufacturer of needle-free injection therapy systems, today reported unaudited financial results for the year and quarter ended December 31, 2012. The financial results are unaudited and actual results may vary.
